Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US4781601046
Ticker JNJ
Company JOHNSON & JOHNSON
Currency $
Price
Aware Investor Index (AII) 6.6359
Recommendation BUY
P/E 28.78
ROE 20.30 %
Capitalization 351,508,212,000 $
Dividend Yield 2.59 %
P/S 4.60
AII Position 121
P/E Position 441
ROE Position 152
Capitalization Position 11
Dividend Yield Position 293
Sales 76,450,000,000 $
10-Year Average Earnings 12,213,800,000 $
Shares Outstanding 2,745,300,000
Equity 60,160,000,000 $
Dividend per Share 3.32 $
Industry Personal Care
Country United States
JOHNSON & JOHNSON Investor Relations Web Site http://www.investor.jnj.com/investor-relations.cfm







Sales:

YEAR MONTH AMOUNT
2017 12 76,450,000,000.00 $
2016 12 71,890,000,000.00 $
2015 12 70,074,000,000.00 $
2014 12 74,331,000,000.00 $
2013 12 71,312,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2017 12 1,300,000,000.00 $
2016 12 16,540,000,000.00 $
2015 12 15,409,000,000.00 $
2014 12 16,323,000,000.00 $
2013 12 13,831,000,000.00 $
2012 12 10,514,000,000.00 $
2011 12 9,672,000,000.00 $
2010 12 13,334,000,000.00 $
2009 12 12,266,000,000.00 $
2008 12 12,949,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2017 12 60,160,000,000.00 $
2016 12 70,418,000,000.00 $
2015 12 71,150,000,000.00 $
2014 12 69,752,000,000.00 $
2013 12 74,053,000,000.00 $
2012 12 64,826,000,000.00 $
2011 12 57,080,000,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2017 12 2,745,300,000
2016 12 2,788,900,000
2015 12 2,812,900,000
2014 12 2,863,900,000
2013 12 2,877,000,000
2012 12 2,812,600,000
2011 12 2,775,300,000

 












Bloomberg News for JOHNSON & JOHNSON:



Google News for JOHNSON & JOHNSON:

Seeking Alpha - 8 hours ago
Johnson & Johnson: P/E Matters
Autogenerated Table 1 below shows the returns for 7 fictitious investors buying shares of Johnson & Johnson (JNJ) over the last 4 years.
KYMA News - 1 hour ago
Pundits Predicting Panic in Johnson & Johnson (JNJ)?
The exact reason why investors have been taking down Johnson & Johnson (NYSE:JNJ) stock at a frenetic pace might seem like a bit of a ...
FinBulletin
Apple, Johnson & Johnson Team Up for Healthcare Project ...
Fellow Action Alerts PLUS holdings Apple Inc. (AAPL) and Johnson & Johnson (JNJ) are collaborating on a study of a new heart health program that combines a ...
Financial Mercury
Stay As Shareholders If The Buyout Goes Through: Johnson ...
Goldman rated the Johnson & Johnson (NYSE:JNJ)'s stock as a Neutral in a research note published on Thursday, July 12th, 2018. Other Wall ...
Money Making News (press release)
Johnson & Johnson, (NYSE: JNJ) – There Is A Convincing Reason ...
JNJ is an exciting player in the Healthcare space, with a center of attention on Drug Manufacturers – Major.Shares of Johnson & Johnson (JNJ) ...
TheStreet.com - 6 hours ago
Was The Recent Price Correction In Johnson & Johnson Stock ...
Johnson & Johnson (NYSE:JNJ) has been facing thousands of lawsuits against its talc products. The stock price recently dropped over 10% ...
Seeking Alpha
Johnson & Johnson (JNJ) Gains But Lags Market: What You Should ...
In the latest trading session, Johnson & Johnson (JNJ) closed at $129.36, marking a +0.84% move from the previous day. This move lagged the ...
StreetInsider.com
Science Favors J&J in Talcum Powder Lawsuits
I would be loading up right now on shares of Johnson & Johnson. After rising nearly 25 percent from the end of May until Dec. 13, the stock ...
MarketWatch
Impressive Free Flow Growth:: Johnson & Johnson, (NYSE: JNJ)
Technical Analysis of Johnson & Johnson: Looking into the profitability ratios of JNJ stock, the shareholder will find its ROE, ROA and ROI ...
NMSU Nеws - 1 day ago
Johnson & Johnson (JNJ) Rating Lowered to Sell at Zacks ...
Johnson & Johnson (NYSE:JNJ) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued ...


Back